$PSNL Thread1: I believe Personalis $PSNL offering another good dip opportunity to load shares here low 30 after hitting ATH 46. It’s been a roller coaster ride but heck of a comeback in 2020.
I own a good position and buying back shares

$PSNL 2
1) Specialize in Cancer Genomics- Next Platform to help with individualized cancer TX and responses
2) Liquid Biopsy that complements ImmunoID NeXT profiling- advantage over competitors since both Biopsy results can be paired with NeXT platform and offering one stop shop.

$PSNL 3
3) Company’s patent for monitoring over 20K genes or 40 times more genes majority of Liquid Biopsy cancer panels on the market. $GH covers 500 plus
4) Per Personalis Total Addressable Market is estimated at about $40bn. See Pic
5) Liquid Biopsy: Projected growth to